{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:58:07Z","timestamp":1778543887307,"version":"3.51.4"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,1]]},"DOI":"10.1097\/qai.0000000000000053","type":"journal-article","created":{"date-parts":[[2013,11,4]],"date-time":"2013-11-04T11:41:36Z","timestamp":1383565296000},"page":"e134-e139","source":"Crossref","is-referenced-by-count":9,"title":["Trends in Procurement Costs for HIV Commodities"],"prefix":"10.1097","volume":"65","author":[{"given":"Francis","family":"Wafula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambrose","family":"Agweyu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Macintyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R11-14-20210131","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1758-2652-13-35","article-title":"A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries.","volume":"13","author":"Waning","year":"2010","journal-title":"J Int AIDS Soc"},{"key":"R14-14-20210131","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.2010.993","article-title":". Use of generic antiretroviral agents and cost savings in PEPFAR treatment programs.","volume":"304","author":"Holmes","year":"2010","journal-title":"JAMA"},{"key":"R15-14-20210131","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2471\/BLT.08.058925","article-title":". Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases.","volume":"87","author":"Waning","year":"2009","journal-title":"Bull World Health Organ"},{"key":"R19-14-20210131","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJM200103153441108","article-title":". The cost-effectiveness of combination antiretroviral therapy for HIV disease.","volume":"344","author":"Freedberg","year":"2001","journal-title":"N Engl J Med"},{"key":"R20-14-20210131","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1744-8603-9-6","article-title":"Antiretrovirals for low income countries: an analysis of the commercial viability of a highly competitive market.","volume":"9","author":"Nakakeeto","year":"2013","journal-title":"Glob Health"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QAI.0000000000000053","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T05:36:46Z","timestamp":1620970606000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-201404010-00014"}},"subtitle":["A 7-Year Retrospective Analysis of Global Fund Data Across 125 Countries"],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0000000000000053","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}